• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of rosuvastatin versus atorvastatin on coronary atherosclerotic plaque volume - a systematic review and meta-analysis with trial sequential analysis of randomized control trials.

作者信息

Kumar Ashish, Shariff Mariam, Doshi Rajkumar

机构信息

Department of Critical Care Medicine, St John's Medical College Hospital, Bengaluru, Karnataka, India.

Department of Internal Medicine, University of Nevada Reno School of Medicine, Reno, USA.

出版信息

Eur J Prev Cardiol. 2020 Dec;27(19):2138-2141. doi: 10.1177/2047487319868035. Epub 2019 Aug 5.

DOI:10.1177/2047487319868035
PMID:31382809
Abstract
摘要

相似文献

1
Impact of rosuvastatin versus atorvastatin on coronary atherosclerotic plaque volume - a systematic review and meta-analysis with trial sequential analysis of randomized control trials.瑞舒伐他汀与阿托伐他汀对冠状动脉粥样硬化斑块体积的影响——一项对随机对照试验进行序贯分析的系统评价和荟萃分析
Eur J Prev Cardiol. 2020 Dec;27(19):2138-2141. doi: 10.1177/2047487319868035. Epub 2019 Aug 5.
2
Comparison of Rosuvastatin Versus Atorvastatin for Coronary Plaque Stabilization.比较瑞舒伐他汀与阿托伐他汀对冠状动脉斑块稳定性的影响。
Am J Cardiol. 2019 May 15;123(10):1565-1571. doi: 10.1016/j.amjcard.2019.02.019. Epub 2019 Feb 23.
3
Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).阿托伐他汀（20 毫克）与瑞舒伐他汀（10 毫克）治疗对轻度冠状动脉粥样硬化斑块的疗效比较（来自 ARTMAP 试验）。
Am J Cardiol. 2012 Jun 15;109(12):1700-4. doi: 10.1016/j.amjcard.2012.01.399. Epub 2012 Mar 20.
4
Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques.比较瑞舒伐他汀与阿托伐他汀对冠状动脉粥样硬化斑块消退效果的荟萃分析。
Am J Cardiol. 2015 Nov 15;116(10):1521-6. doi: 10.1016/j.amjcard.2015.08.010. Epub 2015 Sep 1.
5
Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.比较瑞舒伐他汀和阿托伐他汀对未经治疗的韩国中度冠状动脉狭窄患者斑块消退的影响。
Circ J. 2011;75(2):398-406. doi: 10.1253/circj.cj-10-0658. Epub 2010 Dec 9.
6
Medical Therapy Induced Regression of Plaque in a Female Patient with ASCVD.
Int Heart J. 2019 Jan 25;60(1):175-177. doi: 10.1536/ihj.17-394. Epub 2018 Nov 20.
7
Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin.阿利西尤单抗降低斑块易损性的疗效：在接受瑞舒伐他汀治疗的日本冠心病患者中进行的一项随机对照试验（ALTAIR 研究）的研究方案。
J Cardiol. 2019 Mar;73(3):228-232. doi: 10.1016/j.jjcc.2018.11.012. Epub 2018 Dec 19.
8
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.脂蛋白(a)与长期高强度他汀治疗期间冠状动脉粥样硬化进展速度：来自 SATURN 的研究结果。
Atherosclerosis. 2017 Aug;263:137-144. doi: 10.1016/j.atherosclerosis.2017.06.026. Epub 2017 Jun 15.
9
Efficacy comparison of rosuvastatin and atorvastatin in the treatment of atherosclerosis and drug safety analysis.瑞舒伐他汀与阿托伐他汀治疗动脉粥样硬化的疗效比较及药物安全性分析
Pak J Pharm Sci. 2018 Sep;31(5(Special)):2203-2208.
10
Qualitative plaque stabilization but not quantitative plaque regression.定性斑块稳定而非定量斑块消退。
Circ J. 2012;76(4):809-11. doi: 10.1253/circj.cj-12-0288.

引用本文的文献

1
Comparative effectiveness and safety of atorvastatin versus rosuvastatin among patients with ischemic stroke or transient ischemic attack: a national registry-based observational study.阿托伐他汀与瑞舒伐他汀在缺血性卒中或短暂性脑缺血发作患者中的疗效和安全性比较：一项基于全国登记系统的观察性研究。
EClinicalMedicine. 2025 Jul 24;86:103381. doi: 10.1016/j.eclinm.2025.103381. eCollection 2025 Aug.
2
Rosuvastatin-based combination treatment with acetylsalicylic acid or ezetimibe in the management of patients at high and very high cardiovascular risk. Expert opinion paper of the Polish Lipid Association 2025.基于瑞舒伐他汀联合乙酰水杨酸或依折麦布治疗高心血管风险和极高心血管风险患者。波兰脂质协会2025年专家意见书
Arch Med Sci. 2025 Jan 7;21(1):1-15. doi: 10.5114/aoms/199826. eCollection 2025.
3
Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis.高强度他汀类药物的疗效和安全性比较。系统评价和荟萃分析。
J Comp Eff Res. 2023 Mar;12(3):e220163. doi: 10.57264/cer-2022-0163. Epub 2023 Feb 27.
4
New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins.韩国急性心肌梗死患者接受高强度他汀类药物治疗后新发糖尿病和心血管事件。
BMC Pharmacol Toxicol. 2021 Feb 4;22(1):11. doi: 10.1186/s40360-021-00476-z.
5
Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.比较经皮冠状动脉介入治疗患者中大剂量阿托伐他汀和瑞舒伐他汀的疗效：印度一项非同期队列研究。
PLoS One. 2020 May 19;15(5):e0233230. doi: 10.1371/journal.pone.0233230. eCollection 2020.